ELANCO ANIMAL HEALTH INCORPORATED

(ELAN)
  Report
Delayed Nyse  -  04:00 2022-08-18 pm EDT
18.09 USD   -4.03%
07:55aMorgan Stanley Downgrades Elanco Animal Health to Equalweight From Overweight, Cuts Price Target to $22 From $37, Cites Longer 'Constrained' Visibility
MT
08/17Piper Sandler Trims Price Target on Elanco Animal Health to $21 From $22, Maintains Neutral Rating
MT
08/16Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ Goals
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/12/2022 08/15/2022 08/16/2022 08/17/2022 08/18/2022 Date
20.08(c) 19.36(c) 19.08(c) 18.85(c) 18.09 Last
7 899 874 4 941 992 8 882 558 4 646 799 7 860 827 Volume
+2.61% -3.59% -1.45% -1.21% -4.03% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 4 557 M - -
Net income 2022 -42,9 M - -
Net Debt 2022 5 309 M - -
P/E ratio 2022 -269x
Yield 2022 -
Sales 2023 4 655 M - -
Net income 2023 215 M - -
Net Debt 2023 4 609 M - -
P/E ratio 2023 48,6x
Yield 2023 -
Capitalization 8 937 M 8 937 M -
EV / Sales 2022 3,13x
EV / Sales 2023 2,91x
Nbr of Employees 9 000
Free-Float 95,9%
More Financials
Company
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
More about the company
Ratings of Elanco Animal Health Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ELANCO ANIMAL HEALTH INCORPORATED
07:55aMorgan Stanley Downgrades Elanco Animal Health to Equalweight From Overweight, Cuts Pri..
MT
08/17Piper Sandler Trims Price Target on Elanco Animal Health to $21 From $22, Maintains Neu..
MT
08/16Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress ..
BU
08/16JPMorgan Downgrades Elanco Animal Health to Neutral From Overweight; Price Target is $2..
MT
08/08ELANCO ANIMAL HEALTH INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
08/08TRANSCRIPT : Elanco Animal Health Incorporated, Q2 2022 Earnings Call, Aug 08, 2022
CI
08/08ELANCO ANIMAL HEALTH INCORPORATED : Reports Second Quarter 2022 Results - Form 8-K
PU
08/08Elanco Animal Health Incorporated Provides Earnings Guidance for Third Quarter of 2022
CI
08/08Elanco Animal Health Incorporated Revised Earnings Guidance for Full Year 2022
CI
08/08Elanco Animal Health's Q2 Adjusted Earnings Rise, Revenue Falls; Trims Guidance
MT
08/08Earnings Flash (ELAN) ELANCO ANIMAL HEALTH INCORPORATED Reports Q2 Revenue $1.18B
MT
08/08Earnings Flash (ELAN) ELANCO ANIMAL HEALTH INCORPORATED Posts Q2 EPS $0.36
MT
08/08Elanco Animal Health Reports Second Quarter 2022 Results
BU
08/08Elanco Animal Health Incorporated Reports Earnings Results for the Second Quarter and S..
CI
08/02ELANCO ANIMAL HEALTH INCORPORATED : and Colorado State University's AgNext Announce Strate..
PU
More news
News in other languages on ELANCO ANIMAL HEALTH INCORPORATED
08/08Elanco Animal Health Incorporated fournit des prévisions de résultats pour le troisième..
08/08Elanco Animal Health Incorporated révise ses prévisions de bénéfices pour l'année 2022
08/08Hausse du bénéfice ajusté et baisse du chiffre d'affaires d'Elanco Animal Health au 2e ..
08/08Earnings Flash (ELAN) ELANCO ANIMAL HEALTH INCORPORATED annonce un chiffre d'affaires d..
08/08Elanco Animal Health Incorporated annonce ses résultats pour le deuxième trimestre et l..
More news
Analyst Recommendations on ELANCO ANIMAL HEALTH INCORPORATED
More recommendations
Chart ELANCO ANIMAL HEALTH INCORPORATED
Duration : Period :
Elanco Animal Health Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELANCO ANIMAL HEALTH INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 18,85 $
Average target price 23,56 $
Spread / Average Target 25,0%
EPS Revisions
Managers and Directors
Jeffrey N. Simmons President, Chief Executive Officer & Director
Todd S. Young Chief Financial Officer & Executive Vice President
R. David Hoover Independent Chairman
Christopher Keeley Chief Information Officer & Senior Vice President
David S. Kinard EVP-Human Resources & Corporate Communications
Sector and Competitors
1st jan.Capi. (M$)
ELANCO ANIMAL HEALTH INCORPORATED-33.58%8 937
ZOETIS-29.33%80 735
DECHRA PHARMACEUTICALS PLC-33.52%4 851
BLUESTAR ADISSEO COMPANY-22.97%3 753
VIRBAC-11.43%3 230
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.-5.20%1 866